Schizophrenia Trial, Recruiting NCT01730781 Sponsor: Yale University Condition: Schizophrenia
Back to Schizophrenia

Schizophrenia Trial, Recruiting

NCT01730781
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are male and between 18 and 55 years old
  • If joining as a cannabis user: you are willing to stop using cannabis for four weeks
  • If joining as someone with schizophrenia: you have been formally diagnosed with schizophrenia or schizoaffective disorder (based on DSM-IV-TR standards)
  • If joining as someone at early risk for psychosis: you meet specific criteria for early warning signs of a psychotic illness (confirm with trial site)
  • If joining as someone with a family history of alcoholism: you have a parent, sibling, or child with alcoholism
  • If joining as someone with PTSD: you have been formally diagnosed with Post-Traumatic Stress Disorder (based on DSM-IV-TR standards)
  • If joining as someone with Opioid Use Disorder: you have been formally diagnosed with Opioid Use Disorder (based on DSM-IV-TR standards)

Who may not be able to join:

  • You have a current mental health or nervous system condition, or a serious physical illness, that does not apply to the specific group you would be joining (confirm with trial site)
  • You have any metal implants in your body or a heart pacemaker
  • You have previously been exposed to significant levels of medical radiation that, combined with this study's imaging procedure, would exceed safe limits
  • You experience claustrophobia (fear of enclosed spaces)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Deepak C D'Souza, MD, Yale University

Phone: 203-974-7489

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
1 July 2010
Est. completion
1 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

PET Imaging

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov